Cerebral vein thrombosis and lupus anticoagulant antibodies.
Marietta
M
M
Bertesi
M
M
Simoni
L
L
Castelli
I
I
Cappi
C
C
Torelli
G
G
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000188:drug therapy / Q000209:etiology*; D001327:Autoimmune Diseases / Q000150:complications / Q000276:immunology; D017984:Enoxaparin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000502:physiology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000276:immunology; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000209:etiology; D020225:Sagittal Sinus Thrombosis / Q000188:drug therapy / Q000209:etiology*; D013924:Thrombophlebitis / Q000188:drug therapy / Q000209:etiology; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D017984:Enoxaparin; D016682:Lupus Coagulation Inhibitor; D014859:Warfarin